← Back to Analyst Consensus 
DMAC Buy
DiaMedica Therapeutics Inc.
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 18, 2026 (23 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 11, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Nov 14, 2025 | Cantor Fitzgerald | initiate | — → Overweight | $25 | 50% |
| Aug 15, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Jul 18, 2025 | Craig-Hallum | maintain | Buy → Buy | $11 | 54% |
| Jul 18, 2025 | Lake Street | maintain | Buy → Buy | $14 | 47% |
| Jul 18, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $12 | 44% |
| May 29, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Mar 19, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $10 | 44% |
| Nov 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Oct 10, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Oct 7, 2024 | HC Wainwright & Co. | initiate | — → Buy | $7 | 44% |
| Aug 16, 2024 | Oppenheimer | reiterate | Outperform → Outperform | $6 | 52% |
| Mar 21, 2024 | Craig-Hallum | maintain | Buy → Buy | $8 | 54% |
| Mar 21, 2024 | Oppenheimer | reiterate | Outperform → Outperform | $6 | 52% |
| Jun 22, 2023 | Oppenheimer | upgrade | Perform → Outperform | $7 | 52% |
| Jul 7, 2022 | Lake Street | maintain | — → Buy | $8 | 47% |
| Jul 7, 2022 | Craig-Hallum | maintain | — → Buy | $12 | 54% |
| Jul 7, 2022 | Oppenheimer | downgrade | Outperform → Perform | $0 | 52% |
| Jun 30, 2021 | Roth Capital | maintain | — → Buy | $32 | 53% |
| Apr 8, 2021 | Oppenheimer | initiate | — → Outperform | $27 | 52% |
| Feb 17, 2021 | Roth Capital | initiate | — → Buy | $38 | 53% |
| Jul 8, 2020 | Maxim Group | initiate | — → Buy | $14 | 42% |
| May 15, 2020 | Craig-Hallum | maintain | — → Buy | $15 | 54% |
Price Target Trend
Apr 1, 2026 Latest: $15.5 Oct 23, 2026
EPS Estimates
0y $-0.81
Lo: $-0.88 Hi: $-0.76
4 analysts ▲3
+1y $-0.81
Lo: $-1.05 Hi: $-0.59
5 analysts ▲1
0q $-0.21
Lo: $-0.23 Hi: $-0.19
4 analysts ▲1
+1q $-0.22
Lo: $-0.26 Hi: $-0.19
4 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days